New DiaP277 analogue shifts DCs to tolerogenic, and modulates NF-Kβ1 to suppress autoreactive T lymphocytes in the type 1 diabetic mice

Therapeutic efficacy of P277 against type 1 diabetes was extensively investigated and clinically evidenced. Clinical trials Phases I and II concluded promising results, while the data of P277 immunogenicity in Phase III trials represented weak responses that led to abolish medical use. But, a therap...

Full description

Saved in:
Bibliographic Details
Main Authors: Murad Alahdal (Author), Jing Liangliang (Author), Lu Shiping (Author), Xing Yun (Author), Huashan Gao (Author), Zhou Jialei (Author), Waseem Hassan (Author), Liang Jin (Author), Cao Rongyue (Author)
Format: Book
Published: Taylor & Francis Group, 2018-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available